key: cord-0917529-luw2s26q authors: Sinaci, Selcan; Ocal, Doga F.; Seven, Banu; Anuk, Ali T.; Besimoglu, Berhan; Keven, Mehmet C.; Goncu Ayhan, Sule; Akin, Mustafa S.; Tayman, Cuneyt; Keskin, Huseyin L.; Yapar Eyi, Elif G.; Dinc, Bedia; Moraloglu Tekin, Ozlem; Sahin, Dilek title: Vertical transmission of SARS‐CoV‐2: A prospective cross‐sectional study from a tertiary center date: 2021-06-12 journal: J Med Virol DOI: 10.1002/jmv.27128 sha: e388aefcde73c4a055cd50272c9c204328a227cb doc_id: 917529 cord_uid: luw2s26q The aim was to investigate the association of the delivery mode and vertical transmission of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) through the samples of vaginal secretions, placenta, cord blood, or amniotic fluid as well as the neonatal outcomes. This cross‐sectional study presents an analysis of prospectively gathered data collected at a single tertiary hospital. Sixty‐three pregnant women with confirmed coronavirus disease 2019 (COVID‐19) participated in the study. Vertical transmission of SARS‐CoV‐2 was analyzed with reverse transcriptase‐polymerase chain reaction (RT‐PCR) tests and blood tests for immunoglobulin G (IgG)–immunoglobulin M (IgM) antibodies. All patients were in the mild or moderate category for COVID‐19. Only one placental sample and two of the vaginal secretion samples were positive for SARS‐CoV‐2. Except for one, all positive samples were obtained from patients who gave birth by cesarean. All cord blood and amniotic fluid samples were negative for SARS‐CoV‐2. Two newborns were screened positive for COVID‐19 IgG–IgM within 24 h after delivery, but the RT‐PCR tests were negative. A positive RT‐PCR result was detected in a neof a mother whose placenta, cord blood, amniotic fluid, and vaginal secretions samples were negative. He died due to pulmonary hemorrhage on the 11th day of life. In conclusion, we demonstrated that SARS‐CoV‐2 can be detectable in the placenta or vaginal secretions of pregnant women. Detection of the virus in the placenta or vaginal secretions may not be associated with neonatal infection. Vaginal delivery may not increase the incidence of neonatal infection, and cesarean may not prevent vertical transmission. The decision regarding the mode of delivery should be based on obstetric indications and COVID‐19 severity. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread rapidly, creating an important public health problem worldwide. 1 The risk of severe coronavirus disease 2019 (COVID-19) may be higher during pregnancy than in the general population. 2 Available data on infection risks for pregnant women include fetal distress, abortus, preterm birth, low birth weight, and stillbirth. [3] [4] [5] [6] The transmission of SARS-CoV-2 from mother to fetus, a process termed vertical transmission, is still unclear. Existing studies in the literature have reported that vertical transmission is possible, [7] [8] [9] [10] and these studies mostly focus on placental transfer. There is limited information on the existence of SARS-CoV-2 in the female genital tract and this information may be important for evaluating both vertical and sexual transmission. There is no consensus on the delivery mode and optimal time of delivery in COVID-19 infected women. Moreover, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission is unclear. The issue of vertical transmission and the possibility of neonatal infection is a major concern in COVID-19 infected women. In the current study, we aimed to investigate the association of the delivery mode and vertical transmission of SARS-CoV-2 through vaginal secretions, placenta, cord blood, or amniotic fluid, as well as neonatal outcomes. This prospective study was performed in Ankara City Hospital, Department of Perinatology, Ankara, Turkey, between September 10 and November 23, 2020. Our hospital is one of the leading national pandemic centers which handles approximately 15, 000 deliveries yearly, and our department has extensive experience dealing with COVID-19 infected pregnant women. 11 A total of 63 patients participated in the study ( Figure 1 ). All pregnant women included in the study had positive reverse transcriptase-polymerase chain reaction (RT-PCR) results for SARS- All samples were sent to the molecular microbiology laboratory within 2 h at room temperature; placenta tissues in sterile containers containing PBS, amniotic fluid samples in sterile tubes, vaginal swab samples in tubes containing Viral Transport Medium (various manufacturers), and cord blood samples in tubes containing EDTA. A tissue lysis process was applied to the placenta tissues before nucleic acid isolation. Approximately 2-3 mm 3 of placenta tissue was sectioned and digested on a 65°C heat block with 1000 µl of Buffer ATL (Qiagen) and 50 µl of proteinase K (Qiagen) for a minimum of 3 h. The same procedure was applied to all samples for nucleic acid isolation after tissue lysis. Nucleic acid isolation was performed using the EZ1 Virus Mini Kit v2.0 (Qiagen) with the EZ1 extraction device Positive controls for amplification control and no-template control to assess contamination were used in each run. Thermal cycling was performed in a Rotor-Gene Q device (Qiagen) at 48°C for 20 min for reverse transcription, followed by 95°C for 2 min and then 35 cycles of 95°C for 5 s, 60°C for 10 s. Cycle threshold (C t ) values of less than 35 were defined as positive. Table 3 . A positive PCR result was encountered in a newborn of a mother whose placental, cord blood, amniotic fluid, and vaginal secretion samples were all negative. Moreover, two newborns were screened positive for COVID-19 IgG-IgM (Table 3) . 21, 22 It is revealed that the risk and rate of viral transmission increases as the gestational week progresses. 15 Consistent with the previous reports, we found evidence that SARS-CoV-2 RNA can be found in placentas. Our data showed a term placenta with positive SARS-CoV-2 RNA result in which the pregnancy resulted in a cesarean delivery due to the development of fetal distress. The neonate's RT-PCR test was negative for SARS-CoV-2. Based on this result, we can say that the detection of SARS-CoV-2 in the placenta does not mean RT-PCR positivity in the newborn. In a retrospective analysis comparing 10 positive pregnant women for SARS-CoV-2 with 53 healthy pregnant women, there were no significant differences in neonatal outcomes between the groups, and all neonates were tested negative for SARS-CoV-2. 36 However, confusing reports keep coming. In a recent case, it was reported that a newborn who was positive for SARS-CoV-2 was delivered vaginally from a woman whose rectal and fecal swabs were positive for SARS-CoV-2. 37 And they inferred that using prelabor anorectal swabs in pregnant women who tested positive for COVID-19 may reduce the risk of perinatal transmission during vaginal delivery. They also emphasized that even if the swab results were positive, a vaginal delivery could be performed after safety measures were taken. 32 This can be thought of as a limitation of our study in that we did not perform prelabor anorectal sampling in patients who gave birth vaginally. Safety measures include the use of an enema in the second stage of labor which may potentially prevent stool leakage and reduce the amount of viral load at birth. Similarly, perineal cleaning with standard disinfection methods before the second stage of labor and after the engagement of the fetal head may be useful. 32 To the best of our knowledge, this is the first study examining comprehensive test results of vaginal secretions, placenta, cord blood, or amniotic fluid samples at the same time on pregnant women positive for SARS-CoV-2 and as well as the neonatal outcomes. Vertical transmission of SARS-CoV-2 seems possible. However, evidence supporting vertical transmission is still insufficient. We de- The authors would like to express our gratitude to all healthcare staff for their devoted work for more than one year of the pandemic. Pregnant women and newborns, which is a sensitive population, are carefully protected by the extraordinary courage, high sense of responsibility, excellent medical skills, and tireless work of the healthcare professionals. Authors especially thank Siemens Healthineers Turkey for providing RT-PCR kits for fetal-placental samples as a gift and analyzing the samples. The authors declare that there are no conflicst of interest. Coronavirus disease (COVID-19) outbreak-WHO announces COVID-19 outbreak a pandemic Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: a systematic review Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis Investigating the risk of maternal-fetal transmission of SARS-CoV-2 in early pregnancy COVID-19 positive woman presented with preterm labor: case report Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2 Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth Transplacental transmission of SARS-CoV-2 infection SARS-CoV-2 infection of the placenta Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: a prospective cohort study from Turkey General Directorate of Public Health, COVIḊ-19 (SARS-CoV-2 infection) Guideline Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Viral infections during pregnancy Infections in pregnancy with Covid-19 and other respiratory rna virus diseases are rarely, if ever, transmitted to the fetus: experiences with coronaviruses, HPIV, hMPV RSV, and influenza The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection Perinatal transmission of 2019 coronavirus disease-associated severe acute respiratory syndrome coronavirus 2: should we worry? Intrauterine transmission of SARS-COV-2 infection in a preterm infant Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Antibodies in infants born to mothers with COVID-19 pneumonia Circulatory management focusing on preventing intraventricular hemorrhage and pulmonary hemorrhage in preterm infants Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China Cesarean section or vaginal delivery to prevent possible vertical transmission from a pregnant mother confirmed with COVID-19 to a neonate: a systematic review Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID-19 Vaginal delivery in women with COVID-19: report of two cases Clinical management of severe acute respiratory infection when COVID-19 is suspected Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) infection and pregnancy How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery? SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract Proteomics. Tissuebased map of the human proteome Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it? Vertical transmission of SARS-CoV-2: A prospective crosssectional study from a tertiary center Conceptualization, methodology, literature search, data collection, statistical analysis, and writing the article: Selcan Sinaci. Literature search, statistical analysis and reviewing, and editing the article: Doga F. Ocal.